These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 17251563)

  • 61. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes.
    Bukh J; Miller RH; Purcell RH
    Semin Liver Dis; 1995 Feb; 15(1):41-63. PubMed ID: 7597443
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection.
    Kato N; Ootsuyama Y; Sekiya H; Ohkoshi S; Nakazawa T; Hijikata M; Shimotohno K
    J Virol; 1994 Aug; 68(8):4776-84. PubMed ID: 7518526
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Three-Dimensional Reconstruction of the Hepatitis C Virus Envelope Glycoprotein E1E2 Heterodimer by Electron Microscopic Analysis.
    Kanai T; Hu Z; Yang R; Wu W; Wang Z; Ma CD; Sanchez-Meza J; Law M; Houghton M; Law JL; Logan M; de Val N; Liang TJ
    J Virol; 2023 Jan; 97(1):e0178822. PubMed ID: 36519897
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Intra-host evolutionary dynamics of hepatitis C virus E2 in treated patients.
    Alfonso V; Mbayed VA; Sookoian S; Campos RH
    J Gen Virol; 2005 Oct; 86(Pt 10):2781-2786. PubMed ID: 16186232
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
    Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y
    Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b.
    Majid A; Jackson P; Lawal Z; Pearson GM; Parker H; Alexander GJ; Allain JP; Petrik J
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():317-325. PubMed ID: 10073690
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of hepatitis C virus hypervariable region 1 and its clinical significance.
    Zhang XX; Zhang SY; Liu J; Lu ZM; Wang Y
    World J Gastroenterol; 2003 May; 9(5):1003-7. PubMed ID: 12717846
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Applying antibody-sensitive hypervariable region 1-deleted hepatitis C virus to the study of escape pathways of neutralizing human monoclonal antibody AR5A.
    Velázquez-Moctezuma R; Law M; Bukh J; Prentoe J
    PLoS Pathog; 2017 Feb; 13(2):e1006214. PubMed ID: 28231271
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intensive temporal mapping of hepatitis C hypervariable region 1 quasispecies provides novel insights into hepatitis C virus evolution in chronic infection.
    Schmidt-Martin D; Crosbie O; Kenny-Walsh E; Fanning LJ
    J Gen Virol; 2015 Aug; 96(8):2145-2156. PubMed ID: 25877936
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Structure of the hepatitis C virus E1E2 glycoprotein complex.
    Torrents de la Peña A; Sliepen K; Eshun-Wilson L; Newby ML; Allen JD; Zon I; Koekkoek S; Chumbe A; Crispin M; Schinkel J; Lander GC; Sanders RW; Ward AB
    Science; 2022 Oct; 378(6617):263-269. PubMed ID: 36264808
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Genetic variation characteristics of the envelope region of hepatitis C virus in the patients with chronic hepatitis].
    Chen S; Wang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):219-22. PubMed ID: 12665923
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative analysis of variation and selection in the HCV genome.
    Patiño-Galindo JÁ; González-Candelas F
    Infect Genet Evol; 2017 Apr; 49():104-110. PubMed ID: 28087495
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Inter and intra-host variability of hepatitis C virus genotype 1a hypervariable envelope coding domains followed for a 4-11 year of human immunodeficiency virus coinfection and highly active antiretroviral therapy.
    Sede M; Jones LR; Moretti F; Laufer N; Quarleri J
    Virology; 2014 Dec; 471-473():19-28. PubMed ID: 25461527
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rare HVR1-HCV genotype 1b variants in patients with B non Hodgkin's lymphoma. Comparison with viral sequences detected in cases of lymphoproliferative disorders and B cell compartmentalisation.
    Dettori S; Argentini C; Marcucci F; Spada E; Chionne P; Candido A; Madonna E; Ciccaglione AR; Bianco E; Iannitto E; Musto P; Liso V; De Renzo A; Pagano L; Nieddu G; Pulsoni A; Mele A; Rapicetta M
    New Microbiol; 2007 Jul; 30(3):265-70. PubMed ID: 17802906
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1.
    Lechner S; Rispeter K; Meisel H; Kraas W; Jung G; Roggendorf M; Zibert A
    Virology; 1998 Apr; 243(2):313-21. PubMed ID: 9568031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sequence analysis of the core gene of 14 hepatitis C virus genotypes.
    Bukh J; Purcell RH; Miller RH
    Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8239-43. PubMed ID: 8058787
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
    Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hepacivirus A Infection in Horses Defines Distinct Envelope Hypervariable Regions and Elucidates Potential Roles of Viral Strain and Adaptive Immune Status in Determining Envelope Diversity and Infection Outcome.
    Ramsay JD; Evanoff R; Mealey RH
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.